ArticlePediatric rheumatology online journal2024

The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA.

Grant Schulert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.